Table 1.
Demographics of patients (n = 460).
| Demographic | value |
|---|---|
| Age at diagnosis (y) | |
| ≤65 | 412 (89.6%) |
| >65 | 48 (10.4%) |
| BMI (kg/m 2 ) | |
| ≤30 | 424 (92.2%) |
| >30 | 35 (7.6%) |
| Missing | 1 (0.2%) |
| CA125 | |
| <35 u/ml | 345 (75.0%) |
| ≥35 u/ml | 113 (24.6%) |
| Missing | 2 (0.4%) |
| CA19-9 | |
| ≤27 u/ml | 343 (74.6%) |
| >27 u/ml | 117 (25.4%) |
| CK19 | |
| ≤3.3 ng/ml | 376 (81.7%) |
| >3.3 ng/ml | 84 (18.3%) |
| Myometrial invasion | |
| <50% depth | 357 (77.6%) |
| ≥50% depth | 102 (22.2%) |
| Unknown | 1 (0.2%) |
| Tumor size | |
| <2 cm | 187 (40.7%) |
| ≥2 cm | 273 (59.3%) |
| Ovarian metastasis | |
| Yes | 33 (7.2%) |
| No | 427 (92.8%) |
| Type | |
| I | 278 (60.4%) |
| II | 172 (37.4%) |
| Unknown | 10 (2.2%) |
| FIGO 2009 | |
| I and II | 400 (87.0%) |
| III and IV | 60 (13.0%) |
| Recurrence | 38 |
| Death | 21 |
| Lost to follow-up | 58 |
| Median follow-up time | 20 months (1–60) |
BMI, body mass index.